Showing 8 results

Filters Content type: Editors' picks Conference: HIV Glasgow 2018
Injectable & long-acting HIV treatment

ViiV’s Long-Acting Injectable HIV Regimen Boasts Good 3-Year Results

Editor's pick
Poz
5 November 2018
Cardiovascular disease

Cardiovascular Risk Unclear for HIV Patients on Dolutegravir

Editor's pick
Medscape (requires free registration)
1 November 2018
Starting treatment

Janssen Presents Positive Long-Term Efficacy and Safety of SYMTUZA in Treatment-Naïve Adults with HIV-1

Editor's pick
Janssen press release
1 November 2018
Starting treatment

Gilead Announces 96-Week Results From Phase 3 Study of Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 in Adults New to HIV Therapy

Editor's pick
Gilead press release
1 November 2018
The search for a cure

STEPS V: HIV cure community workshop in Glasgow

Editor's pick
EATG
1 November 2018
Mental & emotional health problems

Experts: Don't Overlook Mental Health in People Living With HIV

Editor's pick
Medpage Today
1 November 2018
New & experimental HIV treatments

Long-lasting HIV injection is a step closer after second GSK study

Editor's pick
Reuters
31 October 2018
Conference announcements & declarations

Treating Resistant HIV, Patient-Centered Care at HIV Glasgow

Editor's pick
Medscape (requires free registration)
23 October 2018